Announcements Trials
Browse Landscape

Phase

Phase 2 32Phase 1 11Phase 3 9Phase NA 8Phase 1/2 5Phase EARLY_PHASE1 2Phase 4 2Phase 2/3 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Polycystic Ovary Syndrome 1Pathologic Complete Response 1

Interventions

Cisplatin 30Magnetic Resonance Spectroscopy 23Carboplatin 23pembrolizumab 21Paclitaxel 20Gemcitabine 19Specimen Handling 16Dexamethasone 15Radiotherapy 14Nivolumab 14Drug Therapy 14Doxorubicin 14Bevacizumab 14atezolizumab 13Oxaliplatin 13Cyclophosphamide 13Radiation 11Pemetrexed 11Cytarabine 11venetoclax 10Vincristine 10Prednisone 10Docetaxel 10Capecitabine 10Trastuzumab 9Temozolomide 8Rituximab 8Platinum 8Ipilimumab 8Fluorouracil 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Metformin × 1 year × Clear all
NCT07585396 2026-05-18

Inositol in Letrozol Resistant PCOS Women

Kafrelsheikh University

Phase 2/3 Completed
36 enrolled

Polycystic Ovary Syndrome

NCT06728982 2025-08-01

Impact Of Metformin In Rectal Cancer Patients

Minia University

Phase 2/3 Completed
85 enrolled

Pathologic Complete Response

Data powered by HemOnc (CC BY 4.0) Colophon âš¡